news roundup
This month’s update includes news from Advanced Clinical, AG Mednet, CTI Clinical Trial and Consulting Services, Ergomed, Novotech, PHASTAR, and many more.
IQVIA Global Compliance has released three new tools aimed at improving regulatory publishing cycle times and productivity: Regulatory Templates, Regulatory PDF Tools, and the eSubmission Validator.
|
|
|
advertisement
Advances in RBM Drive the Clinical Trial of the Future
Access an online resource with useful tools and practical information about advances in RBM. The site provides useful white papers, articles, webcasts, and more.
Access all resources
|
|
Parexel has acquired Model Answers, a consultancy firm based in Brisbane, Queensland, Australia, that provides pharmacokinetic (PK) and pharmacodynamic (PD) modeling, simulation and analysis services to the life sciences industry.
|
|
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »
|
|
advertisement
Three Key Critical Considerations Before Embarking on Decentralized Trials
Available on Demand
Click here to register
|
|
|
|
|
|
|
U.S. and European regulatory officials continue to anticipate drug supply shortages in multiple areas, as are generic drug producers in India, which also obtain APIs from China. FDA also has postponed planned inspections of medical product manufacturers in China due to a State Department travel warning.
|
advertisement
Virtual, Decentralized, Site-less Trials… What Does it All Mean?
Thursday, March 12, 2020 at 11am EDT | 8am PDT | 3pm GMT | 4pm CET
Register now
|
Articles
This article discusses how a quantitative systems pharmacology (QSP)-based approach can be used to predict and better manage immunogencity, taking advantage of bioinformatics data as an input to the model.
|
|
|
advertisement
AI in Action: Clinical Development AI Use Cases
Access an online resource with useful tools and practical information about advances in RBM. The site provides useful white papers, articles, webcasts, and more.
Register now
|
|
|
Blog Posts
The Fostering Age Inclusive Research Trials Initiative maintains that teenagers with cancer are routinely prevented from trying out potentially lifesaving treatments because of a bureaucratic impediments that keep those 18 and under from participating in many trials for new cancer drugs. |
All the interesting things we can use our operational data for relies squarely on its quality. While analyzing data is exciting, unfortunately, cleaning it takes a great deal of time investment. The author shares some data resolutions that will make data more usable.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription
|
|
|
|
|
|
